Campbell, CA – Bayview Legacy, LLC, a principal holder owning more than 10% of Arteris, Inc. (NASDAQ:AIP), has executed a significant reduction in its equity position. The entity sold 70,000 shares of common stock on June 8, 2026, realizing a total transaction value of $2,443,432.
The divestment was structured across two distinct phases. The initial tranche involved the sale of 42,449 shares, executed at a weighted average price of $34.7417 per share. Individual transactions within this block ranged from $33.97 to $34.96. The subsequent phase saw the sale of an additional 27,551 shares at a weighted average price of $35.1596 per share, with prices fluctuating between $34.97 and $35.46. Following these sales, Bayview Legacy, LLC indirectly retained a holding of 8,929,071 shares of Arteris, Inc. common stock.
K. Charles Janac, the manager of Bayview Legacy, LLC and the individual deemed to possess voting and dispositive power over these shares, facilitated the transactions. These sales were executed pursuant to a 10b5-1 trading plan adopted by Janac on March 5, 2025. Janac also filed a separate Form 4 to report these specific transactions, ensuring compliance with regulatory disclosure requirements.
The timing of these sales coincides with notable market movements for Arteris. The stock closed at $33.51 on the day of the transaction, marking a 10% decline over the preceding week. Despite this short-term pullback, the shares have demonstrated significant long-term momentum, surging 307% over the past year. Market analysis from InvestingPro suggests that the stock currently appears overvalued relative to its calculated Fair Value, with 14 additional ProTips available to subscribers for deeper evaluation.
Arteris recently reported financial results for the first quarter of 2026 that surpassed analyst expectations. The company posted earnings per share of -$0.03, outperforming the forecast of -$0.07. Revenue also exceeded projections, with Arteris reporting $22.94 million against a forecast of $21.03 million. Following these results, TD Cowen raised its price target for Arteris shares to $40 from $22, while maintaining a Buy rating. The firm cited the company’s growth in the AI and automotive sectors as key drivers for the upward revision.
Strategic developments in the automotive sector further highlight Arteris’s expanding footprint. The company announced that its technology has been deployed in Li Auto’s L9 Livis SUV. The system IP technology utilized includes Arteris FlexNoC 5 NoC interconnect IP and Magillem SoC integration automation software. This deployment is designed to enhance the vehicle’s AI computational capabilities, with plans for use in future vehicles.
In related market developments, Northland maintained its market perform rating on Intel Corp. following the company’s demonstration of the Clearwater Forest Server CPU. This development indicates Intel’s progress in catching up with Taiwan Semiconductor Manufacturing Co. and Advanced Micro Devices Inc. in the server CPU market. These events underscore the competitive dynamics within the semiconductor and technology sectors, where strategic partnerships and technological advancements continue to drive valuation and market positioning.